Literature DB >> 6193701

Encainide for refractory ventricular tachyarrhythmia.

B Chesnie, P Podrid, B Lown, E Raeder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6193701     DOI： 10.1016/0002-9149(83)90014-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  5 in total

Review 1.  Encainide.

Authors:  M J Antonaccio; A W Gomoll; J E Byrne
Journal:  Cardiovasc Drugs Ther       Date:  1989-10       Impact factor: 3.727

Review 2.  Clinical pharmacokinetics of encainide.

Authors:  D M Roden; R L Woosley
Journal:  Clin Pharmacokinet       Date:  1988-03       Impact factor: 6.447

Review 3.  New antiarrhythmic drugs.

Authors:  P F Nestico; J Morganroth; L N Horowitz
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

4.  Marked Q-T prolongation due to encainide therapy.

Authors:  W Davies; M Jazayeri; P Tchou
Journal:  Cardiovasc Drugs Ther       Date:  1988-09       Impact factor: 3.727

Review 5.  Encainide. A review of its pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; P A Todd
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.